Second Sight Medical (EYES) Reports Q1 Loss of $0.14

Second Sight Medical (NASDAQ: EYES) reported Q1 EPS of ($0.14), versus ($0.16) reported last year. Revenue for the quarter came in at $1 million, versus $1 million reported last year.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Data I/o Corp (DAIO) Misses Q2 EPS by 7c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance